Hemostasis Today

May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Mohammed Elmourtada Abdulgayoom։ New Perspectives on Anemia of Chronic Disease and Its Treatment
Apr 19, 2026, 05:35

Mohammed Elmourtada Abdulgayoom։ New Perspectives on Anemia of Chronic Disease and Its Treatment

Mohammed Elmourtada Abdulgayoom, Clinical Hematology Specialist at Hamad Medical Corporation shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Journal of Haematology։

”I am pleased to share our newly published review in the European Journal of Haematology:

Anemia of Chronic Disease Revisited: Hepcidin Dysregulation, Erythropoietic Failure, and Emerging Roles of SGLT2 Inhibition

In this review, we revisit anemia of chronic disease through the integrated framework of hepcidin dysregulation, iron sequestration, and inflammatory suppression of erythropoiesis. We also discuss the potential role of SGLT2 inhibitors as a physiologic adjunct in the treatment of ACD, through modulation of iron handling, erythropoietic signaling, and inflammatory pathways.

I am grateful to my co-authors Dr. Awni Alshurafa, Dr. Rasha Kaddoura, Dr. Abdulrahman Al-Mashdali , Dr. Shehab Mohamed, and Dr. Mohamed A. Yassin for their valuable collaboration and support.”

Title: Anemia of Chronic Disease Revisited: Hepcidin Dysregulation, Erythropoietic Failure, and Emerging Roles of SGLT2 Inhibition

Authors: Mohammed Abdulgayoom, Awni Alshurafa, Rasha Kaddoura, Abdulrahman F. Al-Mashdali, Shehab F. Mohamed, Mohamed A. Yassin

Mohammed Elmourtada Abdulgayoom։ New Perspectives on Anemia of Chronic Disease and Its Treatment

Stay updated on all scientific advances with Hemostasis Today.